LUCD

Lucid Diagnostics Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website luciddx.com
Employees(FY) -
ISIN US54948X1090

Performance

-2.66%

1W

+11.04%

1M

-33.46%

3M

-31.44%

6M

-35.82%

YTD

-40.07%

1Y

Profile

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma (EAC). It offers EsoCheck, a cell collection device to prevent EAC deaths; and EsoGuard, an Esophageal DNA Test. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Advanced Technical Analysis

Technical Analysis of LUCD 2024-05-10

Overview:

In analyzing the technical indicators for LUCD stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible future stock price movement. By examining these key indicators, we aim to offer valuable insights and recommendations for potential inves...

See more ...

Recent News & Updates

2024-05-14 14:34
Q1 2024 PAVmed Inc Earnings Call(Yahoo Finance)
2024-05-13 20:21
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2024 Earnings Call Transcript(Insidermonkey)
2024-05-13 15:01
Lucid Diagnostics Inc (LUCD) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...(Yahoo Finance)
2024-05-13 08:43
PAVmed Provides Business Update and First Quarter 2024 Financial Results(Prnewswire)
2024-05-13 00:53
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q1 2024(Investorplace)
2024-05-12 20:00
Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results(Prnewswire)
2024-05-08 19:49
Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall(Prnewswire)
2024-05-06 19:39
Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors(Prnewswire)
2024-05-01 20:35
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024(Prnewswire)
2024-05-01 19:49
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard Esophageal Precancer Testing(Prnewswire)
2024-04-28 20:47
Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month(Prnewswire)
2024-04-18 18:00
3 Penny Stocks That Could Make a Big Comeback by the End of Q2(Yahoo Finance)
2024-04-07 20:30
Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference(Prnewswire)
2024-03-27 21:47
PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript(Insidermonkey)
2024-03-27 14:00
Q4 2023 PAVmed Inc Earnings Call(Yahoo Finance)
2024-03-27 00:35
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2023 Earnings Call Transcript(Insidermonkey)
2024-03-27 00:14
Q4 2023 Lucid Diagnostics Inc Earnings Call(Yahoo Finance)
2024-03-26 07:32
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results(Prnewswire)
2024-03-25 10:53
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q4 2023(Investorplace)
2024-03-25 05:30
Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results(Prnewswire)
2024-03-20 21:30
Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard Esophageal Precancer Testing in a Screening Population(Prnewswire)
2024-03-19 20:30
Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference(Prnewswire)
2024-03-11 20:30
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024(Prnewswire)
2024-02-16 04:00
Lucid Diagnostics Provides Update Regarding World Trade Center Health Program(Prnewswire)
2024-02-14 18:45
Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck Esophageal Cell Collection Device during Congressional Testimony(Prnewswire)
2024-02-07 18:45
Lucid Diagnostics Executes Contract to Provide EsoGuard Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors(Prnewswire)
2023-12-17 02:00
The 3 Most Undervalued Penny Stocks to Buy in December(Yahoo Finance)
2023-12-11 19:30
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies(Prnewswire)
2023-12-10 20:00
PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders(Prnewswire)
2023-12-04 03:20
PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split(Prnewswire)

Page 1 of 5

previousnext